BLC
Brown, Lisle/Cummings Portfolio holdings
AUM
$376M
This Quarter Return
+5.82%
1 Year Return
+15.36%
3 Year Return
+61.8%
5 Year Return
–
10 Year Return
–
AUM
$224M
AUM Growth
+$224M
(+13%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
27.71%
Holding
559
New
25
Increased
144
Reduced
59
Closed
2
Top Buys
| 1 |
Canadian National Railway
CNI
|
$1.41M |
| 2 |
JPMorgan Chase
JPM
|
$986K |
| 3 |
T Rowe Price
TROW
|
$832K |
| 4 |
Charles Schwab
SCHW
|
$689K |
| 5 |
Johnson & Johnson
JNJ
|
$676K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$244K |
| 2 |
AB InBev
BUD
|
$179K |
| 3 |
GE Aerospace
GE
|
$150K |
| 4 |
Gilead Sciences
GILD
|
$104K |
| 5 |
Intel
INTC
|
$77.6K |
Sector Composition
| 1 | Healthcare | 17.74% |
| 2 | Technology | 16.33% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 8.85% |
| 5 | Communication Services | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P 500 ETF Trust
SPY
$650B
| $11.9M | 5.31% |
26,774
+142
| +0.5% | +$62.9K |
|
2
Apple
AAPL
$3.39T
| $8.08M | 3.61% |
41,660
+1,490
| +4% | +$289K |
|
3
Microsoft
MSFT
$3.73T
| $6.89M | 3.08% |
20,235
+971
| +5% | +$331K |
|
4
Accenture
ACN
$158B
| $6.39M | 2.86% |
20,706
+1,375
| +7% | +$424K |
|
5
Intercontinental Exchange
ICE
$100B
| $5.9M | 2.64% |
52,150
+3,695
| +8% | +$418K |
|
6
Alphabet (Google) Class A
GOOGL
$2.51T
| $5.3M | 2.37% |
44,275
+3,345
| +8% | +$400K |
|
7
Amazon
AMZN
$2.39T
| $4.79M | 2.14% |
36,755
+1,725
| +5% | +$225K |
|
8
Amgen
AMGN
$154B
| $4.73M | 2.12% |
21,302
+2,573
| +14% | +$571K |
|
|
9
Canadian National Railway
CNI
$60.2B
| $4.08M | 1.82% |
33,668
+11,675
| +53% | +$1.41M |
|
10
Veeva Systems
VEEV
$43.9B
| $3.92M | 1.75% |
19,818
+130
| +0.7% | +$25.7K |
|
11
iShares Short-Term National Muni Bond ETF
SUB
$10.2B
| $3.87M | 1.73% |
37,237
| – | – |
|
12
W.P. Carey
WPC
$14.5B
| $3.86M | 1.73% |
57,120
+8,825
| +18% | +$596K |
|
13
Boston Scientific
BSX
$158B
| $3.77M | 1.69% |
69,692
+6,625
| +11% | +$358K |
|
14
Berkshire Hathaway Class B
BRK.B
$1.08T
| $3.37M | 1.51% |
9,890
+625
| +7% | +$213K |
|
|
15
T Rowe Price
TROW
$23.1B
| $3.35M | 1.5% |
29,900
+7,430
| +33% | +$832K |
|
16
Fiserv
FI
$73.5B
| $3.31M | 1.48% |
26,250
-425
| -2% | -$53.6K |
|
|
17
JPMorgan Chase
JPM
$818B
| $3.16M | 1.41% |
21,737
+6,776
| +45% | +$986K |
|
18
Thermo Fisher Scientific
TMO
$181B
| $2.99M | 1.34% |
5,733
+235
| +4% | +$123K |
|
|
19
Alphabet (Google) Class C
GOOG
$2.52T
| $2.88M | 1.29% |
23,837
| – | – |
|
20
AbbVie
ABBV
$373B
| $2.84M | 1.27% |
21,067
+1,125
| +6% | +$152K |
|
21
Novo Nordisk
NVO
$249B
| $2.72M | 1.22% |
16,795
-215
| -1% | -$34.8K |
|
22
Marsh & McLennan
MMC
$102B
| $2.3M | 1.03% |
12,233
+337
| +3% | +$63.4K |
|
23
Merck
MRK
$212B
| $2.25M | 1.01% |
19,495
+2,895
| +17% | +$334K |
|
24
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $2.17M | 0.97% |
21,801
-200
| -0.9% | -$20K |
|
25
Ecolab
ECL
$78.3B
| $2.14M | 0.96% |
11,470
+25
| +0.2% | +$4.67K |
|